Home › Funds › SCHOLTZ & COMPANY, LLC › VCEL
SCHOLTZ & COMPANY, LLC position in VCEL
VERICEL CORP · Health Care
SCHOLTZ & COMPANY, LLC reported holding 50,034 shares of VCEL (VERICEL CORP) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.06% of its reported portfolio and ranking #33 among its reported holdings. SCHOLTZ & COMPANY, LLC has disclosed VCEL holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SCHOLTZ & COMPANY, LLC's VCEL position evolved
SCHOLTZ & COMPANY, LLC first disclosed a stake in VCEL in Q2 2024 at 29,573 shares (US$1.4M). The position peaked in Q4 2024 at 47,660 shares, worth US$2.6M. Across 7 filings, SCHOLTZ & COMPANY, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 50,034 shares valued at US$2.0M — a reduction of -1,375 shares quarter over quarter.. Notable position changes include a 46% increase in Q3 2024 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 29.57K | $1.36M | New |
| Q3 2024 | 43.10K | $1.82M | Add |
| Q4 2024 | 47.66K | $2.62M | Add |
| Q1 2025 | 50.12K | $2.24M | Add |
| Q2 2025 | 50.57K | $2.15M | Add |
| Q2 2026 | 51.41K | $2.29M | New |
| Q3 2026 | 50.03K | $2.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCEL and 13F data
VCEL (VERICEL CORP) is a Health Care company. 28 other funds we track also report a position in VCEL — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$102.4M), Soleus Capital Management, L.P. (US$64.9M), Conestoga Capital Advisors, LLC (US$63.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCEL
- CONGRESS ASSET MANAGEMENT CO 2.55M sh · $102.44M · Q3 2026
- Soleus Capital Management, L.P. 1.46M sh · $64.92M · Q2 2026
- Conestoga Capital Advisors, LLC 1.57M sh · $63.14M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.30M sh · $52.08M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 708.59K sh · $28.44M · Q3 2026
More on SCHOLTZ & COMPANY, LLC
FAQ
How long has SCHOLTZ & COMPANY, LLC held VCEL?
SCHOLTZ & COMPANY, LLC has disclosed VCEL holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
What is SCHOLTZ & COMPANY, LLC's current position in VCEL?
As of Q3 2026, SCHOLTZ & COMPANY, LLC holds 50.03K shares of VCEL (VERICEL CORP), valued at $2.01M, representing 1.06% of its reported portfolio and ranking #33.
Has SCHOLTZ & COMPANY, LLC been buying or selling VCEL?
In the latest 13F filing (Q3 2026), SCHOLTZ & COMPANY, LLC reduced its position in VCEL. The position peaked in Q4 2024 at 47.66K shares.
Which other funds hold VCEL?
Other major institutional holders of VCEL include CONGRESS ASSET MANAGEMENT CO, Soleus Capital Management, L.P., Conestoga Capital Advisors, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.